Loading...
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However, the optimal duration and sequence of therapy for this disease has yet to be determined. Also, a significant number of patients do not satisfactorily respond to currently available therapies. The Janus kinase (JAK...
Saved in:
| Published in: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315227/ https://ncbi.nlm.nih.gov/pubmed/28255337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16687481 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|